<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Press Coverage

Oral Apixaban Preferable for Preventing Postsurgery VTE in Patients With Gynecologic Cancer

Author Oncology Learning Network | Publish Date August 10, 2020

“Current guidelines recommend a 28-day course of enoxaparin for thromboprophylaxis after surgery for gynecologic cancer,” wrote Saketh R. Guntupalli, Director of the Division of Gynecologic Oncology, University of Colorado School of Medicine, and colleagues.